Travere Therapeutics Inc. ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A. Research Travere Therapeutics' (Nasdaq:TVTX) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance. Travere Therapeutics (NASDAQ:TVTX) Stock Quotes, Forecast and News Summary ; P/E Ratio, - ; Dividend Yield, - ; Exchange, NASDAQ ; RSI. 51 ; Short Interest. %. Travere Therapeutics, Inc. is currently listed on NASDAQ under TVTX. One share of TVTX stock can currently be purchased for approximately $ Investor Q&A Travere Therapeutics is a biopharmaceutical company headquartered in San Diego, California, focused on identifying, developing, and delivering.
SAN DIEGO, July 25, (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ:TVTX) today announced it will report second quarter financial results on. Travere Therapeutics Announces Completion of Public Offering of Common Stock and Pre-Funded Warrants and Exercise in Full of Underwriters' Option to Purchase. Today's High; $ Today's Low; $ 52 Week High; $ 52 Week Low; $ Data Provided by Refinitiv. Minimum 15 minutes delayed. On average, Wall Street analysts predict that Travere Therapeutics's share price could reach $ by Aug 13, The average Travere Therapeutics stock. Looking to buy Travere Therapeutics Stock? View today's TVTX stock price, trade commission-free, and discuss TVTX stock updates with the investor community. Travere Therapeutics, Inc. (TVTX) ; Jul 10, , , , , ; Jul 9, , , , , Travere Therapeutics Inc TVTX:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date09/01/23 · 52 Week Low Find the latest institutional holdings data for Travere Therapeutics, Inc. Common Stock (TVTX) including shareholders, ownership summaries. View the TVTX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Travere Therapeutics. TG Therapeutics Inc common stock. $ TGTX % ; Dyne Therapeutics Inc. $ DYN % ; bluebird bio Inc. $ BLUE % ; Neurocrine Biosciences, Inc. The current price of TVTX is USD — it has increased by % in the past 24 hours. Watch Travere Therapeutics, Inc. stock price performance more closely on.
Stock analysis for Travere Therapeutics Inc (RTRX:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The Investor Relations website contains information about Travere Therapeutics, Inc. 's business for stockholders, potential investors, and financial. Discover real-time Travere Therapeutics, Inc. Common Stock (TVTX) stock prices, quotes, historical data, news, and Insights for informed trading and. Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to. Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life-changing therapies to people living with rare. Stocks Rankings for TVTX. U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred. Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies.
TVTX Travere Therapeutic ; High. ; Low. ; Volume. K ; Open. ; Pre Close. TVTX | Complete Travere Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. While ratings are subjective and will change, the latest Travere Therapeutics (TVTX) rating was a maintained with a price target of $ to $ The. SAN DIEGO, July 25, (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ:TVTX) today announced it will report second quarter financial results on. Analysts' recommendations: Travere Therapeutics, Inc. · Wedbush Adjusts Price Target on Travere Therapeutics to $16 From $13, Maintains Outperform Rating.
Travere Therapeutics Inc (TVTX) ; Buy. 72%Buy. 27%Hold. 0. 0%Sell ; Hold. 0 ; Current $ ; Target $ ; Technicals Summary. Sell. Neutral. Buy. Travere. View the latest Travere Therapeutics Inc. (TVTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Track Travere Therapeutics Inc (TVTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. TVTX - Travere Therapeutics, Inc. (NasdaqGM) - Share Price and News.
The Best Online Tax Filing Service | Best Online Learning Sites